Pharma, Small Cap-Focused Portfolio Managers Beat The Rest In April

Portfolio managers with exposure to pharma, healthcare, small and mid caps gained as these categories outperformed the benchmarks in April when a deadlier second wave of Covid-19 kept investors on the edge.The top 60 portfolio managers on average returned 1.06% gains in April, according to data collated by BloombergQuint from the website of the Securities and Exchange Board of India.But investment approaches benchmarked to the Nifty ...